UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The accuracy of transrectal ultrasonography supplemented with computer‐aided ultrasonography for detecting small prostate cancers

BJU international, 2008-12, Vol.102 (11), p.1560-1565

2008

Volltextzugriff (PDF)

Computer‐aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer

BJU international, 2008-02, Vol.101 (3), p.293-298

2008

Volltextzugriff (PDF)

Mathematical Models to Discriminate Between Benign and Malignant Adnexal Masses: Potential Diagnostic Improvement Using Ovarian HistoScanning

International journal of gynecological cancer, 2011-01, Vol.21 (1), p.35-43

2011

Volltextzugriff (PDF)

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

The New England journal of medicine, 2016-11, Vol.375 (19), p.1823-1833

2016

Volltextzugriff (PDF)

Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2020-05, Vol.38 (14), p.1505-1517

2020

Volltextzugriff (PDF)

HSP40 proteins use class-specific regulation to drive HSP70 functional diversity

Nature (London), 2020-11, Vol.587 (7834), p.489-494

2020

Volltextzugriff (PDF)

Chromatin conformation governs T-cell receptor Jβ gene segment usage

Proceedings of the National Academy of Sciences - PNAS, 2012-09, Vol.109 (39), p.15865-15870

2012

Volltextzugriff (PDF)

Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater

Journal of clinical oncology, 2019-03, Vol.37 (7), p.537-546

2019

Volltextzugriff (PDF)

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50

Journal of clinical oncology, 2021-07, Vol.39 (21), p.2339-2349

2021

Volltextzugriff (PDF)

Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study

Journal of clinical oncology, 2023-04, Vol.41 (11), p.1992-1998

2023

Volltextzugriff (PDF)

Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial

The lancet oncology, 2017-12, Vol.18 (12), p.1600-1609

2017

Volltextzugriff (PDF)

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

The New England journal of medicine, 2018-05, Vol.378 (22), p.2078-2092

2018

Volltextzugriff (PDF)

Aldolase positively regulates of the canonical Wnt signaling pathway

Molecular cancer, 2014-07, Vol.13 (1), p.164-164, Article 164

2014

Volltextzugriff (PDF)

Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1–Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042

JTO clinical and research reports, 2021-08, Vol.2 (8), p.100205-100205, Article 100205

2021

Volltextzugriff (PDF)

Klotho suppresses colorectal cancer through modulation of the unfolded protein response

Oncogene, 2019-02, Vol.38 (6), p.794-807

2019

Volltextzugriff (PDF)

Perforin-Positive Dendritic Cells Exhibit an Immuno-regulatory Role in Metabolic Syndrome and Autoimmunity

Immunity (Cambridge, Mass.), 2015-10, Vol.43 (4), p.776-787

2015

Volltextzugriff (PDF)

Neurotrophic factor-α1 modulates NGF-induced neurite outgrowth through interaction with Wnt-3a and Wnt-5a in PC12 cells and cortical neurons

Molecular and cellular neuroscience, 2015-09, Vol.68, p.222-233

2015

Volltextzugriff (PDF)

Glatiramer acetate reduces Th-17 inflammation and induces regulatory T-cells in the CNS of mice with relapsing–remitting or chronic EAE

Journal of neuroimmunology, 2010-08, Vol.225 (1), p.100-111

2010

Volltextzugriff (PDF)

Abstract CT075: KEYNOTE-189: Randomized, double-blind, phase 3 study of pembrolizumab (pembro) or placebo plus pemetrexed (pem) and platinum as first-line therapy for metastatic NSCLC

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.CT075-CT075

2018

Volltextzugriff (PDF)

624: MicroRNA expression profile in human visceral and subcutaneous adipose tissues during pregnancy: Implications for metabolic adaptations to normal gestation and putative novel mechanism of disease in gestational diabetes mellitus

American journal of obstetrics and gynecology, 2018-01, Vol.218 (1), p.S372-S373

2018

Volltextzugriff (PDF)

Urinary concentration of cytokines in children with acute pyelonephritis

European journal of pediatrics, 2013-06, Vol.172 (6), p.769-774

2013

Volltextzugriff (PDF)

Final analysis of KEYNOTE-189: Pemetrexed-platinum chemotherapy (chemo) with or without pembrolizumab (pembro) in patients (pts) with previously untreated metastatic nonsquamous non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.9582-9582

2020

Volltextzugriff (PDF)

Neurotrophic factor- alpha 1 modulates NGF-induced neurite outgrowth through interaction with Wnt-3a and Wnt-5a in PC12 cells and cortical neurons

Molecular and cellular neuroscience, 2015-09, Vol.68, p.222-233

2015

Volltextzugriff (PDF)

A flow cytometry-based reporter assay identifies macrolide antibiotics as nonsense mutation read-through agents

Journal of molecular medicine (Berlin, Germany), 2016-04, Vol.94 (4), p.469-482

2016

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(47)

Publikationsform

Sprache

Englisch
(46)
Japanisch
(5)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

The accuracy of transrectal ultrasonography supplemented with computer‐aided ultrasonography for detecting small prostate cancers

Computer‐aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer

Mathematical Models to Discriminate Between Benign and Malignant Adnexal Masses: Potential Diagnostic Improvement Using Ovarian HistoScanning

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer

HSP40 proteins use class-specific regulation to drive HSP70 functional diversity

Chromatin conformation governs T-cell receptor Jβ gene segment usage

Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50

Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study

Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial

Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

Aldolase positively regulates of the canonical Wnt signaling pathway

Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1–Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042

Klotho suppresses colorectal cancer through modulation of the unfolded protein response

Perforin-Positive Dendritic Cells Exhibit an Immuno-regulatory Role in Metabolic Syndrome and Autoimmunity

Neurotrophic factor-α1 modulates NGF-induced neurite outgrowth through interaction with Wnt-3a and Wnt-5a in PC12 cells and cortical neurons

Glatiramer acetate reduces Th-17 inflammation and induces regulatory T-cells in the CNS of mice with relapsing–remitting or chronic EAE

Abstract CT075: KEYNOTE-189: Randomized, double-blind, phase 3 study of pembrolizumab (pembro) or placebo plus pemetrexed (pem) and platinum as first-line therapy for metastatic NSCLC

624: MicroRNA expression profile in human visceral and subcutaneous adipose tissues during pregnancy: Implications for metabolic adaptations to normal gestation and putative novel mechanism of disease in gestational diabetes mellitus

Urinary concentration of cytokines in children with acute pyelonephritis

Final analysis of KEYNOTE-189: Pemetrexed-platinum chemotherapy (chemo) with or without pembrolizumab (pembro) in patients (pts) with previously untreated metastatic nonsquamous non-small cell lung cancer (NSCLC)

Neurotrophic factor- alpha 1 modulates NGF-induced neurite outgrowth through interaction with Wnt-3a and Wnt-5a in PC12 cells and cortical neurons

A flow cytometry-based reporter assay identifies macrolide antibiotics as nonsense mutation read-through agents

Suchergebnisse filtern